| Title : Nanomedicine Solutions for Alzheimer's Disease: A Critical Review of Therapeutic Nanoparticle Strategies - Tutubala_2025_ACS.Omega_10_53633 |
| Author(s) : Tutubala TE , Egunlusi AO , Fisher D , Dube A , Joubert J |
| Ref : ACS Omega , 10 :53633 , 2025 |
| Abstract : |
| PubMedSearch : Tutubala_2025_ACS.Omega_10_53633 |
| PubMedID: 41280755 |
| Title : Nanomedicine Solutions for Alzheimer's Disease: A Critical Review of Therapeutic Nanoparticle Strategies - Tutubala_2025_ACS.Omega_10_53633 |
| Author(s) : Tutubala TE , Egunlusi AO , Fisher D , Dube A , Joubert J |
| Ref : ACS Omega , 10 :53633 , 2025 |
| Abstract : |
| PubMedSearch : Tutubala_2025_ACS.Omega_10_53633 |
| PubMedID: 41280755 |
| Title : Nanomedicine Solutions for Alzheimer's Disease: A Critical Review of Therapeutic Nanoparticle Strategies - Tutubala_2025_ACS.Omega_10_53633 |
| Author(s) : Tutubala TE , Egunlusi AO , Fisher D , Dube A , Joubert J |
| Ref : ACS Omega , 10 :53633 , 2025 |
| Abstract : |
| PubMedSearch : Tutubala_2025_ACS.Omega_10_53633 |
| PubMedID: 41280755 |
| Title : Evaluating Blood-Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study - Maboko_2024_Pharmacol.Res.Perspect_12_e70043 |
| Author(s) : Maboko LM , Theron A , Panayides JL , Cordier W , Fisher D , Steenkamp V |
| Ref : Pharmacol Res Perspect , 12 :e70043 , 2024 |
| Abstract : |
| PubMedSearch : Maboko_2024_Pharmacol.Res.Perspect_12_e70043 |
| PubMedID: 39651604 |
| Title : Evaluating Blood-Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study - Maboko_2024_Pharmacol.Res.Perspect_12_e70043 |
| Author(s) : Maboko LM , Theron A , Panayides JL , Cordier W , Fisher D , Steenkamp V |
| Ref : Pharmacol Res Perspect , 12 :e70043 , 2024 |
| Abstract : |
| PubMedSearch : Maboko_2024_Pharmacol.Res.Perspect_12_e70043 |
| PubMedID: 39651604 |
| Title : Evaluating Blood-Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study - Maboko_2024_Pharmacol.Res.Perspect_12_e70043 |
| Author(s) : Maboko LM , Theron A , Panayides JL , Cordier W , Fisher D , Steenkamp V |
| Ref : Pharmacol Res Perspect , 12 :e70043 , 2024 |
| Abstract : |
| PubMedSearch : Maboko_2024_Pharmacol.Res.Perspect_12_e70043 |
| PubMedID: 39651604 |
| Title : Combining CDP-choline and galantamine, an optimized alpha7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia - Choueiry_2019_Int.J.Psychophysiol_145_70 |
| Author(s) : Choueiry J , Blais CM , Shah D , Smith D , Fisher D , Labelle A , Knott V |
| Ref : Int J Psychophysiol , 145 :70 , 2019 |
| Abstract : |
| PubMedSearch : Choueiry_2019_Int.J.Psychophysiol_145_70 |
| PubMedID: 30790597 |
| Title : Combining CDP-choline and galantamine, an optimized alpha7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia - Choueiry_2019_Int.J.Psychophysiol_145_70 |
| Author(s) : Choueiry J , Blais CM , Shah D , Smith D , Fisher D , Labelle A , Knott V |
| Ref : Int J Psychophysiol , 145 :70 , 2019 |
| Abstract : |
| PubMedSearch : Choueiry_2019_Int.J.Psychophysiol_145_70 |
| PubMedID: 30790597 |
| Title : Combining CDP-choline and galantamine, an optimized alpha7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia - Choueiry_2019_Int.J.Psychophysiol_145_70 |
| Author(s) : Choueiry J , Blais CM , Shah D , Smith D , Fisher D , Labelle A , Knott V |
| Ref : Int J Psychophysiol , 145 :70 , 2019 |
| Abstract : |
| PubMedSearch : Choueiry_2019_Int.J.Psychophysiol_145_70 |
| PubMedID: 30790597 |